Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-11-25
DOI
10.3389/fendo.2022.1065856
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- KESTREL and KITE: 52-week results from two Phase III pivotal trials of brolucizumab for diabetic macular edema
- (2022) David M. Brown et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
- (2022) Charles C Wykoff et al. LANCET
- The Long Pentraxin PTX3 as a New Biomarker and Pharmacological Target in Age-Related Macular Degeneration and Diabetic Retinopathy
- (2022) Matteo Stravalaci et al. Frontiers in Pharmacology
- Identification of CCL19 as a Novel Immune-Related Biomarker in Diabetic Nephropathy
- (2022) Hanzhi Chen et al. Frontiers in Genetics
- ACEI and ARB Lower the Incidence of End-Stage Renal Disease among Patients with Diabetic Nephropathy: A Meta-analysis
- (2022) Xiaojuan Deng et al. Computational and Mathematical Methods in Medicine
- Serum lutein is a promising biomarker for type 2 diabetes mellitus and diabetic kidney disease in the elderly
- (2022) Fenghui Pan et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- PANRETINAL PHOTOCOAGULATION VERSUS INTRAVITREAL BEVACIZUMAB VERSUS A PROPOSED MODIFIED COMBINATION THERAPY FOR TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY
- (2022) Toktam Shahraki et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- BMP-7 Upregulates Id2 Through the MAPK Signaling Pathway to Improve Diabetic Tubulointerstitial Fibrosis and the Intervention of Oxymatrine
- (2022) Yawen Xiao et al. Frontiers in Pharmacology
- Interleukin 35 regulates interleukin 17 expression and T helper 17 in patients with proliferative diabetic retinopathy
- (2022) Ai Yan et al. Bioengineered
- Gene Biomarkers Related to Th17 Cells in Macular Edema of Diabetic Retinopathy: Cutting-Edge Comprehensive Bioinformatics Analysis and In Vivo Validation
- (2022) Jing Huang et al. Frontiers in Immunology
- Effects of Pentoxifylline on Serum Markers of Diabetic Nephropathy in Type 2 Diabetes
- (2022) Fatemeh Moosaie et al. Diabetes Therapy
- Fibroblast Growth Factor 21 Levels Exhibit the Association With Renal Outcomes in Subjects With Type 2 Diabetes Mellitus
- (2022) Li-Hsin Chang et al. Frontiers in Endocrinology
- Serum Cystatin C Trajectory Is a Marker Associated With Diabetic Kidney Disease
- (2022) Nana Wang et al. Frontiers in Endocrinology
- Relationship of Soluble Klotho and Early Stage of Diabetic Nephropathy: A Systematic Review and Meta-Analysis
- (2022) Caihong Xin et al. Frontiers in Endocrinology
- Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
- (2022) Chan-Young Jung et al. Diabetes & Metabolism Journal
- Clinical Features and Vitreous Biomarkers of Early-Onset Type 2 Diabetes Mellitus Complicated with Proliferative Diabetic Retinopathy
- (2022) DanDan Ke et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Elevated Retinol Binding Protein 3 Concentrations Are Associated With Decreased Vitreous Inflammatory Cytokines, VEGF, and Progression of Diabetic Retinopathy
- (2022) Ward Fickweiler et al. DIABETES CARE
- Disruption of retinal inflammation and the development of diabetic retinopathy in mice by a CD40-derived peptide or mutation of CD40 in Müller cells
- (2022) Jose-Andres C. Portillo et al. DIABETOLOGIA
- Changes in aqueous and vitreous inflammatory cytokine levels in proliferative diabetic retinopathy: a systematic review and meta-analysis
- (2022) Ryan H. Mason et al. EYE
- Implications of increased circulating macrophage inhibitory protein-5 in patients with type 2 diabetes mellitus
- (2022) Bing Zhao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Nanodisc delivery of liver X receptor agonist for the treatment of diabetic nephropathy
- (2022) Hongliang He et al. JOURNAL OF CONTROLLED RELEASE
- Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration
- (2022) Margaret A. Chang et al. JAMA Ophthalmology
- Diabetic retinopathy: Involved cells, biomarkers, and treatments
- (2022) Jiahui Ren et al. Frontiers in Pharmacology
- Research progress on exosomes/microRNAs in the treatment of diabetic retinopathy
- (2022) Si-ru Niu et al. Frontiers in Endocrinology
- Plasma Apolipoproteins Predicting the Occurrence and Severity of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus
- (2022) Xinyuan Zhang et al. Frontiers in Endocrinology
- CD8+T Cell-Related Gene Biomarkers in Macular Edema of Diabetic Retinopathy
- (2022) Jing Huang et al. Frontiers in Endocrinology
- The extract of Polygala fallax Hemsl. slows the progression of diabetic nephropathy by targeting TLR4 anti-inflammation and MMP-2/9-mediated anti-fibrosis in vitro
- (2022) Minhui Wang et al. PHYTOMEDICINE
- miR-145, miR-92a and miR-375 Show Differential Expression in Serum from Patients with Diabetic Retinopathies
- (2022) Adriana Solis-Vivanco et al. Diagnostics
- Proteomic Analysis of Plasma sEVs Reveals That TNFAIP8 Is a New Biomarker of Cell Proliferation in Diabetic Retinopathy
- (2021) Jing Xiao et al. JOURNAL OF PROTEOME RESEARCH
- MicroRNA-431-5p encapsulated in serum extracellular vesicles as a biomarker for proliferative diabetic retinopathy
- (2021) Bo Yu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- A deep learning system for detecting diabetic retinopathy across the disease spectrum
- (2021) Ling Dai et al. Nature Communications
- Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy
- (2021) David M. Brown et al. JAMA Ophthalmology
- Molecular Features of Classic Retinal Drugs, Retinal Therapeutic Targets and Emerging Treatments
- (2021) Alessandro Arrigo et al. Pharmaceutics
- Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes
- (2021) Stefan Mutter et al. DIABETOLOGIA
- Identification of tear-based protein and non-protein biomarkers: Its application in diagnosis of human diseases using biosensors
- (2021) Sandip K. Nandi et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS
- (2021) Federica Barutta et al. Journal of Translational Medicine
- Angiopoietin-1: an early biomarker of diabetic nephropathy?
- (2021) Alexandra E. Butler et al. Journal of Translational Medicine
- Serum Levels of Plasmalogens and Fatty Acid Metabolites Associate with Retinal Microangiopathy in Participants from the Finnish Diabetes Prevention Study
- (2021) Vanessa Derenji de Mello et al. Nutrients
- Dysregulated Serum Lipid Metabolism Promotes the Occurrence and Development of Diabetic Retinopathy Associated With Upregulated Circulating Levels of VEGF-A, VEGF-D, and PlGF
- (2021) Xinyuan Zhang et al. Frontiers in Medicine
- Correlations Between Different Angiogenic and Inflammatory Factors in Vitreous Fluid of Eyes With Proliferative Diabetic Retinopathy
- (2021) Guanrong Wu et al. Frontiers in Medicine
- Urinary sediment CCL5 messenger RNA as a potential prognostic biomarker of diabetic nephropathy
- (2021) Song-Tao Feng et al. Clinical Kidney Journal
- Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy
- (2021) Eli Ipp et al. JAMA Network Open
- Small Dense Low-Density Lipoprotein Cholesterol is a Potential Marker for Predicting Laser Treatment for Retinopathy in Diabetic Patients
- (2021) Atsuko Nakayama et al. Journal of Atherosclerosis and Thrombosis
- Müller glia-derived exosomal miR-9-3p promotes angiogenesis by restricting sphingosine-1-phosphate receptor S1P1 in diabetic retinopathy
- (2021) Yu Liu et al. Molecular Therapy-Nucleic Acids
- Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial
- (2020) Nete Tofte et al. Lancet Diabetes & Endocrinology
- Evaluation and Care of Patients with Diabetic Retinopathy
- (2020) Lee M. Jampol et al. NEW ENGLAND JOURNAL OF MEDICINE
- Progression of retinopathy and incidence of cardiovascular disease: findings from the Chronic Renal Insufficiency Cohort Study
- (2020) Juan E Grunwald et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study
- (2020) Amanda H. Anderson et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Comprehensive analysis of angiogenesis-related genes and pathways in early diabetic retinopathy
- (2020) Chufeng Gu et al. BMC Medical Genomics
- MicroRNA Expression in the Aqueous Humor of Patients with Diabetic Macular Edema
- (2020) Giuseppina Emanuela Grieco et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Multiplatform Metabolomics Reveals Novel Serum Metabolite Biomarkers in Diabetic Retinopathy Subjects
- (2020) Qiuhui Xuan et al. Advanced Science
- Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs
- (2019) Himanshu Sankrityayan et al. PHARMACOLOGICAL RESEARCH
- The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
- (2019) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Innovative therapies for neovascular age-related macular degeneration
- (2019) Hasenin Al-Khersan et al. EXPERT OPINION ON PHARMACOTHERAPY
- Retinol binding protein 3 is increased in the retina of patients with diabetes resistant to diabetic retinopathy
- (2019) Hisashi Yokomizo et al. Science Translational Medicine
- Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results
- (2019) Catharina Busch et al. ACTA DIABETOLOGICA
- The Need for Multi-Omics Biomarker Signatures in Precision Medicine
- (2019) Michael Olivier et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Evaluation of vascular endothelial growth factor levels in tears and serum among diabetic patients
- (2019) Wen Jeat Ang et al. PLoS One
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2019) Søren L Kristensen et al. Lancet Diabetes & Endocrinology
- Total Protein Concentration and Tumor Necrosis Factor α in Tears of Nonproliferative Diabetic Retinopathy
- (2019) Nurul Hafizah Amil-Bangsa et al. OPTOMETRY AND VISION SCIENCE
- Update on Diabetic Nephropathy: Core Curriculum 2018
- (2018) Kausik Umanath et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Angiopoietin-like 3 Is a Potential Biomarker for Retinopathy in Type 2 Diabetic Patients
- (2018) Cai-Guo Yu et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- The association of serum creatinine and estimated glomerular filtration rate variability with diabetic retinopathy in Asians with type 2 diabetes: A nested case–control study
- (2018) Xiao Zhang et al. Diabetes & Vascular Disease Research
- A non-invasive nanoparticle mediated delivery of triamcinolone acetonide ameliorates diabetic retinopathy in rats
- (2018) Binapani Mahaling et al. Nanoscale
- Glomerular Filtration Rate and/or Ratio of Urine Albumin to Creatinine as Markers for Diabetic Retinopathy: A Ten-Year Follow-Up Study
- (2018) Pedro Romero-Aroca et al. Journal of Diabetes Research
- Incidence and progression of diabetic retinopathy: a systematic review
- (2018) Charumathi Sabanayagam et al. Lancet Diabetes & Endocrinology
- Association between diabetic eye disease and other complications of diabetes: Implications for care. A systematic review
- (2018) Ian Pearce et al. DIABETES OBESITY & METABOLISM
- Dexamethasone protects retinal ganglion cells but not Müller glia against hyperglycemia in vitro
- (2018) Xandra Pereiro et al. PLoS One
- Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes
- (2017) Daniel Shu Wei Ting et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease
- (2017) Steven G. Coca et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Computational image analysis for prognosis determination in DME
- (2017) Bianca S. Gerendas et al. VISION RESEARCH
- Association between Aqueous Cytokines and Diabetic Retinopathy Stage
- (2017) Hailiang Wu et al. Journal of Ophthalmology
- Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes
- (2016) José Antonio M. de Carvalho et al. CLINICAL BIOCHEMISTRY
- Urine Proteome Specific for Eye Damage Can Predict Kidney Damage in Patients With Type 2 Diabetes: A Case-Control and a 5.3-Year Prospective Cohort Study
- (2016) Jin-Kui Yang et al. DIABETES CARE
- Angiopoietins and diabetic nephropathy
- (2016) Luigi Gnudi DIABETOLOGIA
- A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema
- (2016) David G. Callanan et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- An observational study to assess if automated diabetic retinopathy image assessment software can replace one or more steps of manual imaging grading and to determine their cost-effectiveness
- (2016) Adnan Tufail et al. HEALTH TECHNOLOGY ASSESSMENT
- Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study
- (2016) Morten Lindhardt et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria
- (2016) Jan Menne et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
- (2016) John A. Wells et al. OPHTHALMOLOGY
- Diabetic retinopathy
- (2016) Tien Y. Wong et al. Nature Reviews Disease Primers
- Intravitreal Aflibercept for Diabetic Macular Edema
- (2015) David M. Brown et al. OPHTHALMOLOGY
- Neutrophil Gelatinase-Associated Lipocalin as an Early Sign of Diabetic Kidney Injury in Children
- (2015) Zeynep Yürük Yıldırım et al. Journal of Clinical Research in Pediatric Endocrinology
- The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial
- (2015) Dick de Zeeuw et al. Lancet Diabetes & Endocrinology
- The Role of Dipeptidyl Peptidase – 4 Inhibitors in Diabetic Kidney Disease
- (2015) Usha Panchapakesan et al. Frontiers in Immunology
- Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial
- (2014) C. Joergensen et al. DIABETIC MEDICINE
- Effect of Pentoxifylline on Renal Function and Urinary Albumin Excretion in Patients with Diabetic Kidney Disease: The PREDIAN Trial
- (2014) J. F. Navarro-Gonzalez et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Role of elevated serum uric acid levels at the onset of overt nephropathy in the risk for renal function decline in patients with type 2 diabetes
- (2014) Kentaro Tanaka et al. Journal of Diabetes Investigation
- (Pro)renin receptor is associated with angiogenic activity in proliferative diabetic retinopathy
- (2012) A. Kanda et al. DIABETOLOGIA
- Benefits of Renin-Angiotensin Blockade on Retinopathy in Type 1 Diabetes Vary With Glycemic Control
- (2011) Tasma Harindhanavudhi et al. DIABETES CARE
- Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin–angiotensin–aldosterone system inhibition
- (2011) Min Jeong Kim et al. KIDNEY INTERNATIONAL
- A Phase 2/3, Multicenter, Randomized, Double-Masked, 2-Year Trial of Pegaptanib Sodium for the Treatment of Diabetic Macular Edema
- (2011) Marla B. Sultan et al. OPHTHALMOLOGY
- The RESTORE Study
- (2011) Paul Mitchell et al. OPHTHALMOLOGY
- Avosentan for Overt Diabetic Nephropathy
- (2010) J. F.E. Mann et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Ocular immune privilege
- (2009) A W Taylor EYE
- The Effect of Pentoxifylline on Proteinuria in Diabetic Kidney Disease: A Meta-analysis
- (2008) Brendan B. McCormick et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials
- (2008) Nish Chaturvedi et al. LANCET
- Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial
- (2008) Anne Katrin Sjølie et al. LANCET
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started